DLL3 and small cell lung carcinoma: Given the substantial overlap in EV DLL3 expression between SCLC patients and HRS, we conducted a combined analysis of DLL3 Exo‐mRNA and tEV‐mProtein expression as a dual‐biomarker for SCLC detection.